Wheeze Detection Using Aevice Medical Device
A Pilot Study to Assess Aevice Medical Device for Detection of Wheeze in Pediatric Subjects and Use for Remote Auscultation
1 other identifier
observational
35
1 country
1
Brief Summary
The primary objective of this study is to determine if Aevice Medical Device can detect wheeze as accurately as a physician through auscultation. The secondary objective is to investigate if Aevice Medical Device can be used for remote auscultation of the lung.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 23, 2021
CompletedFirst Submitted
Initial submission to the registry
December 17, 2021
CompletedFirst Posted
Study publicly available on registry
January 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2024
CompletedJune 4, 2025
May 1, 2025
2.2 years
December 17, 2021
May 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Wheeze is detected by physician and AeviceMD
Primary end point of wheeze will be captured in a binary fashion (i.e. PRESENT or NOT PRESENT) on the CRF by the physician during manual auscultation. AeviceMD will perform wheeze analysis on each 5 sec of recording
60 Seconds
Secondary Outcomes (1)
Respiratory sounds are detected and identified by onsite physician and offsite (remote) physician
150 Seconds
Interventions
The AeviceMD will be placed on the patient to detect wheeze and perform auscultation.
Eligibility Criteria
Study will include 35 patients who are admitted for exacerbations of chronic airway disease (i.e. Asthma)
You may qualify if:
- The subject is willing and parents/guardians are able to give informed consent for participation in the study.
- Male or Female, aged 3 -18 years.
- Presenting with wheeze.
- Able (in the Investigators opinion) and willing to comply with all study requirements
You may not qualify if:
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aevice Health Pte. Ltd.lead
- National University Hospital, Singaporecollaborator
Study Sites (1)
National University Hospital
Singapore, Singapore, 119074, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2021
First Posted
January 18, 2022
Study Start
April 23, 2021
Primary Completion
July 18, 2023
Study Completion
July 18, 2024
Last Updated
June 4, 2025
Record last verified: 2025-05